|
21.06.2010
The German Cancer Research Center and Life Technologies have signed an extensive agreement that will see the cancer researchers receiving expensive latest-generation DNA sequencers at no cost, and the Americans benefiting from German experience and expertise.
|
|
25.05.2010
The BIO Convention in Chicago opened its gates on 4 May. While still the largest industry gathering of its kind, the number of exhibitors fell to a new low of 1700.
|
|
24.05.2010
At a conference in Montpellier in the south of France, prominent molecular biologists and bioinformaticians from around the world discussed how to drive forward genome research towards the establishment of the so-called bioeconomy. The experts want to develop strategy paper together with the OECD.
|
|
20.05.2010
More than 200 experts from academia and industry met to discuss future developments in biotechnologically produced medicines at the second Cooperation Forum “Biopharmaceuticals” in the Benediktbeuern monastery.
|
|
15.05.2010
Efforts to reduce carbon dioxide emissions cost energy companies a great deal. As an alternative to algae, RWE is now also pressing ahead with the use of bacteria to cut their own CO2 emissions. The microbes are used to convert the climate-killing gas into valuable raw materials.
|
|
07.05.2010
The German biotechnology industry is outgrowing the crisis. In 2009, there was growth in the number of jobs and products. These are some of the results of the latest company survey carried out by biotechnologie.de on behalf of the Federal Ministry of Education and Research.
|
|
27.04.2010
Untroubled by volcanic travel difficulties effecting so many others, over 500 biotech experts recently met in Berlin for a national industry forum. The German Biotechnology Days 2010 has provided ample material for discussion: From financing, the bio-economy, to personalized medicine, industrial biotechnology and beyond.
|
|
15.03.2010
1,800 representatives of biotechnology and pharmaceutical companies made their way to a snowy Barcelona for Bio-Europe’s spring outing. For pharmaceutical companies, who conducted over 8,000 individual interviews, the focus was on securing good ideas from small start-ups as early as possible.
|
|
07.01.2010
The German biotechnology industry is keeping calm in the face of the financial crisis. This is underlined by the latest survey of public opinion conducted by Bio Deutschland and the industry magazine |transkript.
|
|
07.01.2010
A German-Spanish research team has fully characterised one of the world’s simplest living creatures. In the search for the fundamentals of life, they have concluded that simple does not necessarily mean simplistic.
|
